News
Neurotherapeutics wins Medilink Midlands ‘one t...
At an awards night on 27th Jan 2022 Neurotherapeutics won the ‘One to watch’ award. Professor Stephen and Georgina Jackson attended the awards ceremony and accepted the award. Stephen Jackson...
Neurotherapeutics wins Medilink Midlands ‘one t...
At an awards night on 27th Jan 2022 Neurotherapeutics won the ‘One to watch’ award. Professor Stephen and Georgina Jackson attended the awards ceremony and accepted the award. Stephen Jackson...
Professor Stephen Jackson appointed Chair of th...
Professor Stephen Jackson was Recently appointed Chair of the Scientific Advisory Board for the Federation of European Societies for Neuropsychology (FESN).
Professor Stephen Jackson appointed Chair of th...
Professor Stephen Jackson was Recently appointed Chair of the Scientific Advisory Board for the Federation of European Societies for Neuropsychology (FESN).
MHRA Approval for use of Clinical investigation...
Neurotherapeutics Ltd received MHRA approval to use prototype clinical investigation devices in a new clinical study which will start in March 2022. This study will investigate the impact of median...
MHRA Approval for use of Clinical investigation...
Neurotherapeutics Ltd received MHRA approval to use prototype clinical investigation devices in a new clinical study which will start in March 2022. This study will investigate the impact of median...
Neurotherapeutics Ltd listed as finalists in Me...
Neurotherapeutics Ltd has been shortlisted as a finalist for the Medilink Midlands Business Awards 2022 in 3 categories: ONE TO WATCH - Awarded to a business that shows a great...
Neurotherapeutics Ltd listed as finalists in Me...
Neurotherapeutics Ltd has been shortlisted as a finalist for the Medilink Midlands Business Awards 2022 in 3 categories: ONE TO WATCH - Awarded to a business that shows a great...